WF
MRK icon

Wayfinding Financial’s Merck MRK Stock Holding History

Wayfinding Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Sell
2,307
-53
-2% -$6.12K 0.12% 116
2025
Q4 		$250K Buy
+2,360
New +$222K 0.11% 124
2025
Q2 		– Sell
-4,231
Closed -$383K – 510
2025
Q1 		$383K Sell
4,231
-56
-1% -$5.23K 0.17% 85
2024
Q4 		$429K Buy
+4,287
New +$442K 0.23% 75
2024
Q3 		– Sell
-4,163
Closed -$518K – 95
2024
Q2 		$518K Sell
4,163
-1,156
-22% -$149K 0.29% 65
2024
Q1 		$689K Buy
5,319
+435
+9% +$53.6K 0.4% 52
2023
Q4 		$536K Sell
4,884
-294
-6% -$30.5K 0.36% 55
2023
Q3 		$534K Sell
5,178
-239
-4% -$25.8K 0.4% 50
2023
Q2 		$576K Buy
5,417
+357
+7% +$40.5K 0.4% 50
2023
Q1 		$542K Buy
5,060
+384
+8% +$41.5K 0.41% 48
2022
Q4 		$376K Sell
4,676
-273
-6% -$27.9K 0.3% 58
2022
Q3 		$429K Buy
4,949
+85
+2% +$7.59K 0.4% 41
2022
Q2 		$446K Buy
4,864
+19
+0.4% +$1.68K 0.39% 45
2022
Q1 		$428K Buy
4,845
+169
+4% +$13.3K 0.36% 48
2021
Q4 		$376K Buy
+4,676
New +$372K 0.3% 58

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wayfinding Financial's MRK Position: Q1 2026 in Review

Wayfinding Financial reduced its Merck (MRK) stake by 2.2% in Q1 2026, selling an estimated $6.12K and leaving 2,307 shares worth $279K. The position accounts for 0.12% of the portfolio, ranked #116.

Wayfinding Financial first reported a position in MRK in Q4 2021 and has held it in 15 quarters since. The position peaked at $689K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wayfinding Financial held 2,307 shares of Merck worth $279K as of Q1 2026.
  • Wayfinding Financial sold 53 Merck shares in Q1 2026, an estimated $6.12K.
  • Merck made up 0.12% of Wayfinding Financial's portfolio in Q1 2026, its #116 holding.
  • Wayfinding Financial first reported a position in Merck in Q4 2021 and has held it in 15 quarters since.
  • Wayfinding Financial's Merck position peaked at $689K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wayfinding Financial's 13F filing for Q1 2026, filed 12 May 2026.